
Kaitlan Collins @kaitlancollins
The CDC's Advisory Committee on Immunization Practices will meet Wednesday to discuss potential Pfizer boosters for those ages 12-15, meaning likely no stamp of approval from the CDC director on this until then at least. — PolitiTweet.org